Stoke Therapeutics, Inc. - Common Stock, par value $0.0001 per share (STOK)

Q: What does CUSIP 86150R107 represent in this 13F holders report?

CUSIP 86150R107 is the security identifier for STOK - Stoke Therapeutics, Inc. - Common Stock, par value $0.0001 per share used to aggregate holder disclosures.

Q: How many institutions held STOK - Stoke Therapeutics, Inc. - Common Stock, par value $0.0001 per share in Q4 2020?

93 institutional investors reported STOK - Stoke Therapeutics, Inc. - Common Stock, par value $0.0001 per share for Q4 2020. Use the holders table for investor-level position and value details.

CUSIP: 86150R107

Q4 2020 13F Holders as of 31 Dec 2020

Type / Class: Equity / Common Stock, par value $0.0001 per share
Shares outstanding: 57,529,259
Total 13F shares: 38,644,696
Share change: +4,008,011
Total reported value: $2,393,196,414
Put/Call ratio: 11%
Price per share: $61.93
Number of holders: 93
Value change: +$252,468,837
Number of buys: 47
Number of sells: 35

Quarterly Holders Quick Answers

What is CUSIP 86150R107?
CUSIP 86150R107 identifies STOK - Stoke Therapeutics, Inc. - Common Stock, par value $0.0001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Related Filing Research

Latest 13F filings for newly reported positions.
Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
Latest 10-Q/10-K reports for financial context tied to this issuer.
Recent insider transactions for executive and insider activity.
SEC investors directory and top value investors for manager drilldown.
Back to full security ownership history.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q1 2021
Previous quarter: Q3 2020

Recent filing periods for CUSIP 86150R107:

Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024

Institutional Holders of Stoke Therapeutics, Inc. - Common Stock, par value $0.0001 per share (STOK) as of Q4 2020

As of 31 Dec 2020, Stoke Therapeutics, Inc. - Common Stock, par value $0.0001 per share (STOK) was held by 93 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 38,644,696 shares. The largest 10 holders included ATP Life Science Ventures, L.P., FMR LLC, RTW INVESTMENTS, LP, Redmile Group, LLC, BlackRock Inc., VANGUARD GROUP INC, GILDER GAGNON HOWE & CO LLC, Cormorant Asset Management, LP, FEDERATED HERMES, INC., and PRICE T ROWE ASSOCIATES INC /MD/. This page lists 93 institutional shareholders reporting positions in this security for the Q4 2020 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.